CS
SWTX

Candriam SCA’s SpringWorks Therapeutics SWTX Stock Holding History

Candriam SCA’s Portfolio SWTX Stock Details SWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-96,778
Closed -$4.27M – 722
2025
Q1 		$4.27M Sell
96,778
-67,237
-41% -$3.1M 0.03% 364
2024
Q4 		$5.93M Sell
164,015
-681,155
-81% -$23.8M 0.03% 328
2024
Q3 		$27.1M Buy
845,170
+323,066
+62% +$12.1M 0.16% 141
2024
Q2 		$19.7M Buy
522,104
+321,476
+160% +$13.5M 0.12% 171
2024
Q1 		$9.87M Sell
200,628
-75,000
-27% -$3.47M 0.06% 257
2023
Q4 		$10.1M Buy
275,628
+125,002
+83% +$3.26M 0.07% 249
2023
Q3 		$3.48M Hold
150,626
– – 0.02% 358
2023
Q2 		$3.95M Buy
150,626
+139,136
+1,211% +$3.66M 0.03% 371
2023
Q1 		$272K Sell
11,490
-150,619
-93% -$4.4M ﹤0.01% 858
2022
Q4 		$4.22M Hold
162,109
– – 0.03% 419
2022
Q3 		$4.63M Hold
162,109
– – 0.03% 396
2022
Q2 		$3.99M Hold
162,109
– – 0.03% 360
2022
Q1 		$9.15M Sell
162,109
-10,447
-6% -$598K 0.06% 270
2021
Q4 		$10.7M Buy
172,556
+31,722
+23% +$2.1M 0.07% 255
2021
Q3 		$8.94M Hold
140,834
– – 0.06% 296
2021
Q2 		$11.6M Buy
140,834
+4,955
+4% +$376K 0.08% 265
2021
Q1 		$9.47M Sell
135,879
-1
-0% -$78 0.08% 258
2020
Q4 		$9.86M Buy
+135,880
New +$8.75M 0.08% 264

Other funds holding SWTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
BCM
Beryl Capital Management Redondo Beach, California $111M AUM 205.39% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return

Candriam SCA's SWTX Position: Q2 2025 in Review

Candriam SCA sold out of SpringWorks Therapeutics (SWTX) in Q2 2025, closing a stake of 96,778 shares — an estimated $4.27M sold.

Candriam SCA first reported a position in SWTX in Q4 2020 and held it in 18 quarters. The position peaked at $27.1M in Q3 2024. 223 funds tracked by Wall St. Rank hold SWTX as of Q2 2025.

  • Candriam SCA reported no remaining SpringWorks Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Candriam SCA sold 96,778 SpringWorks Therapeutics shares in Q2 2025, an estimated $4.27M.
  • Candriam SCA first reported a position in SpringWorks Therapeutics in Q4 2020 and held it in 18 quarters.
  • Candriam SCA's SpringWorks Therapeutics position peaked at $27.1M in Q3 2024.
  • 223 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q2 2025.

Based on Candriam SCA's 13F filing for Q2 2025, filed 8 Aug 2025.